社区老年肌少症患者血浆脑源性神经营养因子浓度升高
该研究纳入246名50-82岁社区成人,采用EWGSOP2标准诊断肌少症,检测血浆BDNF浓度。结果显示肌少症患者血浆BDNF较对照组高47.6%,诊断曲线下面积为0.702,BDNF>1645 pg/ml与肌少症风险升高相关。
要点
- 社区肌少症患者血浆BDNF浓度较无肌少症者高47.6%。
- BDNF>1645 pg/ml者肌少症风险为≤1645 pg/ml者的2.83倍。
- BDNF对肌少症诊断的AUC为0.702,切点>1645 pg/ml。
核心结论
- 社区居住的肌少症患者血浆BDNF浓度升高,可能反映神经肌肉重塑增加。
研究设计与样本
- 研究纳入246名50-82岁社区成人(平均年龄63.6岁,52%女性),采用握力计和双能X线吸收法评估肌力和骨骼肌指数,按EWGSOP2算法诊断肌少症。
主要发现
- 肌少症患者血浆BDNF浓度较对照组高47.6%(P=0.005)。
- 血浆BDNF诊断肌少症的AUC为0.702(95%CI=0.597-0.806,P=0.002),最佳切点为>1645 pg/ml。
- 血浆BDNF>1645 pg/ml者肌少症风险为≤1645 pg/ml者的2.83倍(95%CI=1.13-7.11,P=0.027)。
- BDNF Z-score≥2者肌少症风险为Z-score<1者的5.14倍(95%CI=1.16-22.82,P=0.031)。
关键数值与推荐
- 肌少症诊断采用EWGSOP2算法,依据低握力或低骨骼肌指数。
- BDNF诊断肌少症的最佳切点为>1645 pg/ml,AUC=0.702(95%CI=0.597-0.806)。
临床怎么用
- 血浆BDNF可作为社区肌少症评估的候选循环标志物,但尚需进一步验证。
局限性
- 原文未报告研究设计类型、样本代表性及BDNF与肌少症因果关系的机制验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The scalability of a blood-based sarcopenia assessment has generated interest in circulating markers that may enhance management strategies. Data regarding the relevance of brain derived neurotrophic factor (BDNF), a regulator of neuroplasticity, to sarcopenia in community-dwelling adults are scarce. We examined the association between plasma BDNF concentrations, sarcopenia and individual sarcopenia signatures in a well-characterised adult cohort. METHODS: Participants included 246 men and women aged 50-82 years (mean age = 63.6 years; 52% female). Muscle strength and skeletal muscle index (SMI) were assessed by hand dynamometry and dual-energy X-ray absorptiometry. Plasma BDNF concentrations were determined, in duplicate, with commercially available enzyme-linked immunosorbent assays. Sarcopenia and individual signatures of sarcopenia (i.e. low grip strength or low SMI) were diagnosed according to the EWGSOP2 algorithm. RESULTS: Plasma BDNF concentrations were 47.6% higher in participants with sarcopenia than controls (P = 0.005), and demonstrated acceptable diagnostic accuracy (areas under the curves = 0.702, 95%CI = 0.597-0.806, P = 0.002, optimal cut-off >1645 pg/ml). Plasma BDNF concentration >1645 pg/ml was associated with 2.83 greater odds for sarcopenia (95%CI = 1.13-7.11, P = 0.027), than ≤1645 pg/ml, whilst a BDNF Z-score ≥2 was associated with 5.14 higher odds for sarcopenia (95%CI = 1.16-22.82, P = 0.031), than a Z-score <1. Covariates included sex, age, body mass index, habitual physical activity, smoking status, alcohol consumption, comorbidity and educational attainment. CONCLUSION: Circulating BDNF concentrations are elevated in community-dwelling men and women with sarcopenia, which may reflect increased neuromuscular remodelling in these people. Our findings complement existing data, supporting the presence of an intricate relationship between neural integrity and skeletal muscle health. Future studies are needed to establish the mechanistic pathways that may underpin the associations.
引用
- Pratt J, Motanova E, Narici MV, et al. Plasma brain-derived neurotrophic factor concentrations are elevated in community-dwelling adults with sarcopenia. Age Ageing. 2025. PMID: 39957555. doi:10.1093/ageing/afaf024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。